🔎 Trials Near Me

Home › Macular Degeneration › Florida

Macular Degeneration clinical trials in Florida

14 studies for Macular Degeneration are looking for participants at sites in Florida.

Cities in Florida

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

  • Retina Group of Florida, Fort Lauderdale
  • VitreoRetinal Associates, PA, Gainesville
  • Retina Specialty Institute, Pensacola
  • and 1 more
RecruitingPhase 2/3
Ages 60 and older · All sexes · Updated Sep 30, 2026 · NCT06635148

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

  • Advanced Retina Institute-Ophthalmology, Bonita Springs
  • Advanced Research, Coral Springs
  • Retina Group of Florida, Fort Lauderdale
  • and 11 more
RecruitingPhase 3
Ages 50 to 85 · All sexes · Updated Sep 18, 2026 · NCT06541704

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

  • Florida Eye Clinic (Site 130), Altamonte Springs
  • Retina Group of Florida (Site 070), Fort Lauderdale
  • Vitreo Retinal Associates, Gainesville
  • and 9 more
RecruitingPhase 2/3
Ages 50 and older · All sexes · Updated Sep 18, 2026 · NCT07440225

A Phase 2 Study of NT-101 Topical in Patients With Wet AMD

  • Advanced Retina Institute, Bonita Springs
RecruitingPhase 2
Ages 50 and older · All sexes · Updated Sep 16, 2026 · NCT07811726

Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD

  • Florida Retina Institute, Orlando
  • Retina Specialty Institute, Pensacola
  • Retina Group of Florida, Sarasota
  • and 1 more
RecruitingPhase 2
Ages 55 and older · All sexes · Updated Sep 10, 2026 · NCT06659445

A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults

  • University of Florida Health - UF Health Jacksonville, Jacksonville
  • University of Miami Health System - Bascom Palmer Eye Institute, Miami
RecruitingObservational study
Ages 6 and older · All sexes · Updated Aug 25, 2026 · NCT07425574

4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration

  • Retina Group of Florida, Fort Lauderdale
  • Vitreo Retinal Associates, Gainesville
  • Florida Eye Associates, Melbourne
  • and 2 more
RecruitingPhase 1/2
Ages 50 and older · All sexes · Updated Aug 21, 2026 · NCT05197270

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)

  • Retina Group of Florida, Fort Myers
  • Florida Retina Institute, Orlando
  • Retina Group of Florida (Site 065), Sarasota
  • and 1 more
RecruitingPhase 2/3
Ages 50 and older · All sexes · Updated Aug 6, 2026 · NCT07496567

Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration

  • Adverum site 124, Deerfield Beach
  • Adverum site 176, Fort Lauderdale
  • Adverum site 168, Jacksonville
RecruitingPhase 2
Ages 50 and older · All sexes · Updated Aug 5, 2026 · NCT07630649

Stem Cell Ophthalmology Treatment Study II

  • MD Stem Cells, Coral Springs
Recruiting
Ages 18 and older · All sexes · Updated Jun 29, 2026 · NCT03011541

Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

  • ClearVista Clinical Research, Hudson
  • Florida Retina Institute, Orlando
  • Retina Specialty Institute, Pensacola
  • and 3 more
RecruitingPhase 3
Ages 50 and older · All sexes · Updated Apr 16, 2026 · NCT07064759

Study to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration

  • CBCC Global Research Site:006, Deerfield Beach
RecruitingPhase 1
Ages 50 and older · All sexes · Updated Feb 7, 2025 · NCT06132035

Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD

  • Sarasota Retina Institute, Sarasota
Recruiting
Ages 65 and older · All sexes · Updated Dec 3, 2024 · NCT05438732

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.